Premium Member
Dr. Lucas Fernandez
CONICET — Instituto de Investigaciones Biomedicas, Buenos Aires
Argentina
Argentina
1
Articles
0
Followers
6
Views
Molecular biologist and pharmacologist at CONICET investigating novel drug targets in neurodegenerative disease. His lab pioneered a CRISPR-based screening platform for identifying tau aggregation inhibitors in Alzheimer's disease models.
Member since May 2026
Biomedical Research
CRISPR Screens, Tau Pathology, and the Search for Novel Alzheimer's Drug Targets
No publications listed yet.